The nocebo effect: A clinicians guide
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Objective: This paper aims to provide an overview on the nocebo effect, focusing on recognition — its phenomenology, at-risk demographic profiles, clinical situations and personality factors, as well as discriminating somatic symptoms in the general population from treatment-related adverse effects. Lastly, the paper addresses available evidence-based strategies for management and minimisation of the nocebo effect. Method: Data for this paper were identified by searching PubMed using the search terms "nocebo" and “nocebo effect”, augmented by a manual search of the references of the key papers and the related literature. Results: The nocebo effect refers to non-pharmacodynamic, harmful or undesirable effects occurring after inactive treatment, a phenomenon that also occurs in the context of active therapy. Known drivers include classical conditioning and negative expectations concerning treatment. Recent meta-analyses have reported a considerable prevalence, ranging from 18% in the symptomatic treatment of migraine, to more than 74% in multiple sclerosis. Recognition of the nocebo-driven adverse effects presents a challenge, especially because of its non-specific nature and the similarity to the active medication’s expected profile. Traits such as neuroticism, pessimism and type A personalities may predispose individuals to this phenomenon. Clinical management of the nocebo effect includes awareness and recognition, changing the manner of disclosure of potential drug-related adverse effects, shaping patients’ expectations and enhancing the treatment alliance. Conclusion: The nocebo effect is a common, clinically significant, yet covert driver of clinical outcomes. Increased awareness of its features, as well as knowledge of strategies on how to manage it, are fundamental so that clinicians can mitigate its impact on clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04315.2003 · Cited by 788 · cited 1×
“Two dominant psychological mechanisms are thought to be involved in the nocebo response — expectation and classical conditioning (Benedetti et al., 2003).”
BackgroundNonspecific medication side effects and the nocebo phenomenon
Barsky, A. J. (2002) · JAMA · doi:10.1001/jama.287.5.622 · Cited by 784
The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect
Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2947-06.2006 · Cited by 419 · cited 2×
“Changes in the hypothalamic-pituitary-adrenal axis, including rises in adrenocorticotrophic hormone and cortisol, have been linked to pain perception and expectation (Benedetti et al., 2006; Johansen et al., 2003).”
BackgroundThe role of learning in nocebo and placebo effects
Colloca, L., Sigaudo, M., & Benedetti, F. (2008) · Pain · doi:10.1016/j.pain.2008.02.006 · Cited by 411 · cited 1×
“The finding that both expectations and prior conditioning are relevant in the development of noceboinduced hyperalgaesia has been replicated, and it appears that the duration of the conditioning positively influences the perpetuation of the nocebo effect (Colloca et al., 2008; Colloca et al., 2010).”
BackgroundSomatization Symptoms and Hypochondriacal Features in the General Population
Rief, W., Hessel, A., & Braehler, E. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200107000-00012 · Cited by 339
How the number of learning trials affects placebo and nocebo responses
Colloca, L., Petrovic, P., Wager, T. D., Ingvar, M., & Benedetti, F. (2010) · Pain · doi:10.1016/j.pain.2010.08.007 · Cited by 300 · cited 1×
“The finding that both expectations and prior conditioning are relevant in the development of noceboinduced hyperalgaesia has been replicated, and it appears that the duration of the conditioning positively influences the perpetuation of the nocebo effect (Colloca et al., 2008; Colloca et al., 2010).”
BackgroundA functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect
Kong, J., Gollub, R. L., Polich, G., Kirsch, I., LaViolette, P., Vangel, M., Rosen, B., & Kaptchuk, T. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2944-08.2008 · Cited by 263 · cited 2×
“A positron emission tomography study reported changes in μ-opioid and dopamine D2/D3 neurotransmission with the nocebo effect, and functional magnetic resonance imaging studies have suggested the involvement of specific brain structures, such as anterior cingulate, insula and the prefrontal cortex (Kong et al., 2008;…”
BackgroundBlockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide
Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A., & Maggi, G. (1997) · Pain · doi:10.1016/s0304-3959(97)03346-0 · Cited by 238 · cited 1×
“Cholecystokinin pathways may additionally mediate the link between anxiety and pain in nocebo-induced hyperalgaesia (Benedetti et al., 1997; Benedetti et al., 2006).”
BackgroundGeers, A. L., Helfer, S. G., Kosbab, K., Weiland, P. E., & Landry, S. J. (2005) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2004.08.011 · Cited by 225
Rief, W., Nestoriuc, Y., von Lilienfeld-Toal, A., Dogan, I., Schreiber, F., Hofmann, S. G., Barsky, A. J., & Avorn, J. (2009) · Drug Safety · doi:10.2165/11316580-000000000-00000 · Cited by 202 · cited 1×
“One consequence of expectation is that nocebo-driven side effects tend to resemble the ones known to be part of a medication’s profile or the expected symptoms of the disorder, adding opacity to interpretation (Mitsikostas et al., 2012; Rief et al., 2009; Amanzio et al., 2009).”
Background
Research works printed but not linked: 46
- 10.1016/j.pain.2009.07.010 · DOI · Paper page
- 10.1097/00006842-198809000-00007 · DOI · Paper page
- 10.1111/j.1399-5618.2004.00154.x · DOI · Paper page
- 10.1097/00006842-199211000-00001 · DOI
- 10.1016/S0006-3223(00)00966-5 · DOI
- 10.1007/s12160-010-9186-4 · DOI · Paper page
- 10.1016/S1474-4422(04)00908-1 · DOI · Paper page
- 10.1097/00004714-199510000-00007 · DOI · Paper page
- 10.1002/cncr.24751 · DOI · Paper page
- 10.1016/S0140-6736(00)04169-6 · DOI · Paper page
- 10.1111/j.1365-2125.1995.tb04434.x · DOI · Paper page
- 10.1080/10810730150501413 · DOI · Paper page
- 10.1037/0022-3514.77.2.370 · DOI
- 10.1016/j.jpsychores.2006.12.005 · DOI
- 10.1016/j.contraception.2010.06.010 · DOI
- 10.1006/pmed.1996.0124 · DOI · Paper page
- 10.1007/s00127-006-0082-y · DOI · Paper page
- 10.1097/01.PSY.0000082626.56217.CF · DOI · Paper page
- Kennedy WP, 1961, Medical World, 95, 203
- 10.1016/j.jpsychores.2008.09.019 · DOI
- 10.1073/pnas.0408576102 · DOI · Paper page
- Liccardi G, 2004, Journal of Investigational Allergology and Clinical Immunology, 14, 104
- 10.1177/0163278706293403 · DOI
- Lombardi C, 2008, European Annals of Allergy and Clinical Immunology, 40, 138
- 10.1056/NEJM197205252862105 · DOI · Paper page
- 10.1016/j.mehy.2011.08.029 · DOI
- 10.1111/j.1468-1331.2011.03528.x · DOI
- 10.1177/0333102410391485 · DOI
- 10.1111/j.1743-6109.2007.00563.x · DOI · Paper page
- 10.1038/clpt.1987.142 · DOI · Paper page
- 10.1016/S0895-4356(96)00177-1 · DOI · Paper page
- 10.1007/s00415-011-6197-4 · DOI
- 10.1177/1352458510370793 · DOI · Paper page
- 10.1016/0163-8343(81)90052-9 · doi:10.1016/0163-8343(81)90052-9
- 10.1046/j.1526-4610.2003.03216.x · DOI
- 10.1038/clpt.1993.190 · DOI · Paper page
- 10.1001/archgenpsychiatry.2007.34 · DOI · Paper page
- 10.1007/s002280050413 · DOI
- 10.1016/j.ehj.2003.08.016 · DOI · Paper page
- 10.1016/S0022-3956(00)00039-X · DOI
- Thaler RH, 2008, Nudge: Improving Decisions about Health, Wealth, and Happiness
- 10.1016/S0165-0327(97)00125-0 · DOI
- 10.1016/j.pain.2011.01.043 · DOI · Paper page
- 10.1213/ANE.0b013e3181cc5727 · DOI · Paper page
- 10.1080/10810730701854011 · DOI
- 10.1007/s00228-008-0494-6 · DOI · Paper page
Cited by
Antidépresseurs et tolérance : déterminants et prise en charge des principaux effets indésirables
David, D. J., & Gourion, D. (2016) · L'Encéphale · doi:10.1016/j.encep.2016.05.006 · Cited by 105
Corsi, N., Emadi Andani, M., Tinazzi, M., & Fiorio, M. (2016) · Scientific Reports · doi:10.1038/srep30671 · Cited by 44
The Other Side of the Coin: Nocebo Effects and Psychotherapy
Locher, C., Koechlin, H., Gaab, J., & Gerger, H. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00555 · Cited by 25
Metadata
- Authors
- Data-Franco, J., & Berk, M.
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2012-10-23
- Volume
- 47
- Issue
- 7
- Pages
- 617-623
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W1997613912
- Cited by
- 55
- References
- 14
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The nocebo effect: A clinicians guide. https://app.cochat.ai/papers/10.1177/0004867412464717
- The paper
- Data-Franco, J., & Berk, M. (2013). The nocebo effect: A clinicians guide. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/0004867412464717
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.